Current and future perspectives for wastewater-based epidemiology as a monitoring tool for pharmaceutical use

摘要

The medical and societal consequences of the misuse of Pharmaceuticals clearly justify the need for comprehensive drug utilization research (DUR). Wastewater-based epidemiology (WBE) employs the analysis of human metabolic excretion products in wastewater to monitor consumption patterns of xenobiotics at the population level. Recently, WBE has demonstrated its potential to evaluate lifestyle factors such as illicit drug, alcohol and tobacco consumption at the population level, in near real-time and with high spatial and temporal resolution. Up until now there have been fewer WBE studies investigating health biomarkers such as Pharmaceuticals. WBE publications monitoring the consumption of Pharmaceuticals were systematically reviewed from three databases (PubMed, Web of Science and Google Scholar). 64 publications that reported population-normalised mass loads or defined daily doses of Pharmaceuticals were selected. We document that WBE could be employed as a complementary information source for DUR. Interest in using WBE approaches for monitoring pharmaceutical use is growing but more foundation research (e.g. compound-specific uncertainties) is required to link WBE data to routine pharmacoepidemiologic information sources and workflows. WBE offers the possibility of i) estimating consumption of Pharmaceuticals through the analysis of human metabolic excretion products in wastewater; ⅱ) monitoring spatial and temporal consumption patterns of Pharmaceuticals continuously and in near real-time; and ⅲ) triangulating data with other DUR information sources to assess the impacts of strategies or interventions to reduce inappropriate use of Pharmaceuticals.